The FDA has approved a combination of two drugs for the treatment of patients with BRAF V600E mutation-positive metastatic non-small cell lung cancer. This is great news as it adds another targeted therapy to treatment options. fda.gov/drugs/informationon...
New treatment for lung cancers with a ... - Lung Cancer Support
New treatment for lung cancers with a BRAF mutation
Written by
MFH_Advocate
To view profiles and participate in discussions please or .
Read more about...
2 Replies
•
Another treatment to add to the arsenal. We need all the help we can get.
scifiknitterBlogger
This is indeed great news!
Not what you're looking for?
You may also like...
A new drug for ALK-positive lung cancer approved today
The FDA has approved a new drug for patients with ALK-positive lung cancer. The drug is called...
FDA Approves Tecentriq for First-Line Treatment of Metastatic NSCLC with High PD-L1 Expression
On May 18th, 2020, the Food and Drug Administration (FDA) approved Tecentriq (atezolizumab) for the...
FDA approves another blood test for a mutation (T790M) in lung cancer
Some of you may have heard about new blood tests to check for lung cancer mutations. And you may...
New here and fighting lung and bone cancers
I am new here, and this is my very first post.
Back on January 5, 2016 I was given 6-12 months to...
Lung Cancer Treatment
Have been diagnosed with lung cancer again (but now on the right), 6 years later, but this time...
New drug approved for patients with MET mutation. 
CBD FOR LUNG CANCER?
New Member: Living with Stage 4 Lung Cancer and Advocating for Awareness and Research
